HealthPartners Awarded $6M To Advance Telemonitoring Study

One patient from Apple Valley credits her participation in the early stage study for her prolonged life.

HealthPartners received $6 million to support a high blood pressure study it claims to be “groundbreaking.”
Researchers at the Bloomington-based HealthPartners Institute will use the newly acquired funds to expand the scope of their study to a wider pool of patients.
A Washington D.C.-based nonprofit called the Patient-Centered Outcomes Research Institute (PCORI) awarded HealthPartners as part of a multi-million dollar funding package it divvies out each year to a select group of projects.
The HealthPartners study—referred to as Hyperlink—attempts to see if a patient can decrease their blood pressure with the assistance of telemonitoring. Rather than relying exclusively on in-person appointments, patients in the study are given a blood pressure measuring device to use at home. Readings from the device are sent to the patient’s pharmacist or nurse practitioner six times each week, which allows medical personnel to tailor treatment. As a result, fewer visits to a primary doctor are required.
In a statement, Dr. Karen Margolis of HealthPartners said the continued research could provide new and improved treatment procedures for those with high blood pressure. “A two to three point drop in a blood pressure reading over a sustained period can make the difference between having or not having a stroke or heart attack,” she said.
Pat Buchholz of Apple Valley, one of the Hyperlink study's initial 450 subjects, claimed the telemonitoring she’s received from HealthPartners over the study’s early years has extended her lifespan.
“It has given me these years and I hope I have many more,” Buchholz said.
HealthPartners will continue its Hyperlink study pending a programmatic and business review by the PCORI.